- Trials with a EudraCT protocol (143)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (25)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: Nisylen Tabletten Beobachtungsstudie |
| Active substance: Aconitum Trit. D3 25 mg Gelsemium Trit. D3 25 mg Phosphorus Trit. D5 25 mg Bryonia Trit. D2 25 mg Eupatorium perfoliatum Trit. D1 25 mg |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39737 |
| Study title: A MULTICENTER, RANDOMIZED, INVESTIGATOR-BLINDED, PARALLEL GROUP COMPARISON OF ADAPALENE GEL (CD271G) 0.1% AND ITS VEHICLE IN THE TREATMENT OF ACNE VULGARIS - PHASE III |
| Active substance: ADAPALENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46290 |
| Study title: Acute toxicity of KWD2183 in young rats after single oral administration |
| Active substance: BAMBUTEROL HYDROCHLORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22123 |
| Study title: General toxicity of KWD2183 given orally to young rats for three months |
| Active substance: BAMBUTEROL HYDROCHLORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22124 |
| Study title: General toxicity of bambuterol (KWD2183) given orally to young rats for three months. Plasma concentration study. (Appendix 4:2 to report T2030) |
| Active substance: BAMBUTEROL HYDROCHLORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22125 |
| Study title: Multinationale und multizentrische Anwendungsbeobachtung mit Tonsiotren® H gemäß §67, 6 AMG bei Patienten mit akuter Angina bzw. akuter Exazerbation einer chronischen rezidivierenden Angina |
| Active substance: Atropinum sulfuricum Trit. D5 12,5 mg Hepar sulfuris Trit. D3 (nach Vorschrift 6 HAB) 10,0 mg Kalium bichromicum Trit. D4 50,0 mg Silicea Trit. D2 5,0 mg Mercurius bijodatus Trit. D8 25,0 mg |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39740 |
| Study title: Pharmacokinetic of a 80000 UI Vitamine D2 ampoule in eutrophic newborns |
| Active substance: ERGOCALCIFEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26408 |
| Study title: Cetirizin effects on children with atopic dermatitis. correlation among the eosinophil cationic protein (ecp), il2r soluble (cd25), cd23 (b cells) and clinical score. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23689 |
| Study title: A multi-centre, randomised, double-blind, parallel group study to validate the changes in tidal breathing lung function parameters versus FEV1 and PD20 assessments due to anti-inflammatory treatment in 5 to 10 years old mild to moderately symptomatic children with asthma. Extensive searching has revealed that no clinical report is available for this study. The clinical trial results were reported via publications; see citation below. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FMS30002-ICHE3.pdf |
| View full study record |
| Document reference: 28397 |
| Study title: Observational study Hypotonie-Gastreu R44 |
| Active substance: (HMP) Crataegus D1, Laurocerasus D3, Oleander D3, Spartium scoparium D2 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39734 |
| Study title: Efficacy of Tonsilotren in the treatment of acute angina catarrhalis. |
| Active substance: (Homeopathic) Per tablet: Atropinum sulfuricum D5 12,5 mg Hepar sulfuris D3 10,0 mg Kalium bichromicum D4 50,0 mg Silicea D2 5,0 mg Mercurius bijodatus D8 25,0 mg |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39745 |
| Study title: Modulation of the immediate allergic wheal reaction in the skin by drugs inhibiting the effects of leukotriene C4 and prostaglandin D2. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29970 |
| Study title: Application of Intravenous Contrast in PET/CT:Does It Really Introduce Significant Attenuation Correction Error?J Nucl Med 2005; 46:283–291. Yat-Yin Yau, MD1; Wing-Sze Chan, BSc1; Yat-Man Tam, MSc1; Phil Vernon, PhD2; So Wong1; Marc Coel, MD3; and Simon Kwok-Fai Chu1 |
| Active substance: Steripet |
| Study summary document link (including results): yau-2005.pdf |
| View full study record |
| Document reference: 48747 |
| Study title: NHS dental epidemology programme for England2010-Rooney |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 2010-Rooney-NHS dental epidemology programme for England.pdf |
| View full study record |
| Document reference: 49092 |
| Study title: Clinical Performance of PET/CT in Evaluation of Cancer: Additional Value for Diagnostic Imaging and Patient ManagementRachel Bar-Shalom, MD1; Nikolai Yefremov, MD1; Ludmila Guralnik, MD2; Diana Gaitini, MD2,3; Alex Frenkel, DSc1; Abraham Kuten, MD3,4; Hernan Altman, MBA5; Zohar Keidar, MD, PhD1; and Ora Israel, MD1,3. THE JOURNAL OF NUCLEAR MEDICINE • Vol. 44 • No. 8 • August 2003 |
| Active substance: Steripet |
| Study summary document link (including results): bar-shalom-2003.pdf |
| View full study record |
| Document reference: 48623 |
| Study title: Comparison of 18F-FDG and 11C-Methionine for PET-Guided Stereotactic Brain Biopsy of GliomasJ Nucl Med 2004; 45:1293–1298. Benoit Pirotte, MD1; Serge Goldman, MD, PhD2; Nicolas Massager, MD1; Philippe David, MD3; David Wikler, MS1; Arlette Vandesteene, MD, PhD4; Isabelle Salmon, MD, PhD5; Jacques Brotchi, MD, PhD1; and Marc Levivier, MD, PhD1 |
| Active substance: Steripet |
| Study summary document link (including results): pirotte-2004.pdf |
| View full study record |
| Document reference: 48742 |
| Study title: Effects on the respiratory tract and male reproductive organs in young rats given formoterol fumarate (D2522) in lactose by the inhalation route for 3 months |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47838 |
| Study title: Single dose toxicity of formoterol fumarate (D2522) in young rats after oral administration. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47863 |
| Study title: Comparison of stepwise treatment of asthmatic children with salmeterol/fluticasone propionate (FP) combination product (Seretide) and/or fluticasone propionate (Flixotide) based on PD20 methacholine plus symptoms or based on symptoms only (Children Asthma Therapy Optimal”) |
| Active substance: FLUTICASONE AND SALMETEROL |
| Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAS30018-ICHE3.pdf |
| View full study record |
| Document reference: 28451 |
| Study title: Testicular effects of formoterol fumarate (D2522) given orally to young rats for three months, using salbutamol sulphate as a reference compound |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47867 |
